Schenectady, NY – April 26th, 2021 – EndoSoft® is excited to announce that the U.S. Patent and Trademark Office has issued a new patent titled AI Systems for Detecting & Sizing Lesions (#10,957,043). The issuance of this patent paves the way for the use of our clinical decision support software, Argus®, & further strengthens the company’s offerings within the GI space and dedication to improving the quality of gastroenterological procedures.
Colorectal cancer is the third leading cause of cancer-related death in the United States, and early detection is paramount to prevention. To aid in early detection, the patent protects the developed technology of a trained classifier that uses machine learning (ML) for detection and uses a deep learning algorithm to size lesions through a live video feed in real-time to referenced objects during a clinical procedure.
“The most challenging task for any gastroenterologist is to improve their adenoma detection rate (ADR) by detecting polyps at an early stage and save lives”, said Rakesh Madan, President & CEO of EndoSoft®. “While working with gastroenterologists for over 25 years, we saw the challenge in real-time and responded by developing a solution that increases the polyp detection rate and assists with the sizing of the polyp during the procedure for proper recall, as per clinical standards”.
“Argus® is an artificial intelligence (AI) and machine learning (ML) technology that integrates readily with most any endoscopy report writer (ERW) or electronic health records (EHR) software.” said Zohair Hussain, VP of Development at EndoSoft®. “We wanted Argus® to be easy to implement and use, so we made it vendor neutral.”
Information on the newly issued patent can be found here.
About Argus®
Argus® is an AI solution powered by EndoSoft® that integrates with any Electronic Health Record (EHR), scopes, and processors. Argus® is launched during the endoscopy procedure to aid in the decision-making of polyp detection and sizing. Argus® assists clinicians with the detection of polyps and abnormalities. Argus® utilizes artificial intelligence (AI) and machine learning while capturing images simultaneously.
Disclaimer: Argus® is clinical decision support software that functions within an EMR and is not intended for use as a medical device. It does not make a diagnosis, identify suspected adenomas, or direct treatment decisions, but it does organize information for the clinicians relating to polyps. It is not intended to substitute for the advice of a clinician. The clinician should always use proper judgment in patient care and should disregard Argus® recommendations where clinically appropriate.
About EndoSoft®
From a solo provider’s practice to large multi-specialty hospital systems, EndoSoft® applications are used by more than 50,000 clinical users worldwide, becoming one of the most trusted names in healthcare technology. EndoSoft®’s offerings include EndoVault®, a market-leading EMR tailored for a multitude of endoscopic specialties, including gastroenterology, ENT, OB/GYN, pathology, orthopedics, cardiology, pain management, pulmonology, oncology, ophthalmology, dermatology, and urology. The software is comprised of modules for procedure documentation, image management, nursing, reporting, scheduling, and inventory management. EndoVault® is also compliant with multiple international standards, including Meaningful Use and IHE.
